File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Safety and tolerability of subcutaneous trastuzumab and intravenous pertuzumab as adjuvant treatment for HER2 positive breast cancer: a pilot study

TitleSafety and tolerability of subcutaneous trastuzumab and intravenous pertuzumab as adjuvant treatment for HER2 positive breast cancer: a pilot study
Authors
Wong, CYLeung, RCYKwok, GWTsang, JLi, CWYau, TCCChiu, WYJ
Issue Date2021
Citation
Postgrad Med J, 2021, p. postgradmedj-2021-140319 How to Cite?
DOI: http://dx.doi.org/10.1136/postgradmedj-2021-140319
Persistent Identifierhttp://hdl.handle.net/10722/304699
ISI Accession Number ID
WOS:000728115100001

 

DC FieldValueLanguage
dc.contributor.authorWong, CY-
dc.contributor.authorLeung, RCY-
dc.contributor.authorKwok, GW-
dc.contributor.authorTsang, J-
dc.contributor.authorLi, CW-
dc.contributor.authorYau, TCC-
dc.contributor.authorChiu, WYJ-
dc.date.accessioned2021-10-05T02:33:52Z-
dc.date.available2021-10-05T02:33:52Z-
dc.date.issued2021-
dc.identifier.citationPostgrad Med J, 2021, p. postgradmedj-2021-140319-
dc.identifier.urihttp://hdl.handle.net/10722/304699-
dc.languageeng-
dc.relation.ispartofPostgrad Med J-
dc.titleSafety and tolerability of subcutaneous trastuzumab and intravenous pertuzumab as adjuvant treatment for HER2 positive breast cancer: a pilot study-
dc.typeArticle-
dc.identifier.emailLi, CW: bryanli@hku.hk-
dc.identifier.emailYau, TCC: tyaucc@hku.hk-
dc.identifier.emailChiu, WYJ: jwychiu@hku.hk-
dc.identifier.authorityYau, TCC=rp01466-
dc.identifier.authorityChiu, WYJ=rp01917-
dc.identifier.doi10.1136/postgradmedj-2021-140319-
dc.identifier.scopuseid_2-s2.0-85106887065-
dc.identifier.hkuros326277-
dc.identifier.spagepostgradmedj-
dc.identifier.epage2021-
dc.identifier.isiWOS:000728115100001-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats